Competence Centre TEDD
Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement).
During this TEDD Annual Meeting, we would like to show MPS application diversity across different industries.
DATE: 14 October 2021
PLACE: ZHAW, Wädenswil, Switzerland
- TEDD Partner (two participants) Free of charge
- TEDD Partner (third and next participant) CHF 80.00
- Standard Fee CHF 160.00
- Students CHF 80.00
Registration deadline 1 October 2021.
IMPORTANT UPDATE: We must legally ask all participants to provide their Covid Certificates with QR code together with an identification document (ID, passport) during TEDD Annual Meeting 2021. Please read more here. If you have any question contact us at email@example.com.
TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.